background image

Multiple Myeloma Clinical Trials

Find clinical trials for multiple myeloma. Search for multiple myeloma clinical trials in different cities and states across the United States.

Filter
1

Elotuzumab, CC-92480, Dexamethasone

Recruiting
PHASE1

Sponsor:

Abdullah Khan

Location:

Columbus OH

Code:

NCT05981209

Conditions

Recurrent Multiple Myeloma

Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Dexamethasone

RRMM

Recruiting
PHASE2

Sponsor:

Multiple Myeloma Research Consortium

Location:

Duarte CA, Boston MA, Detroit MI, St. Louis MOshow 3 more

Code:

NCT06171685

Conditions

Relapse Multiple Myeloma

Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Teclistamab Monotherapy

Teclistamab

ABBV-383

Recruiting
PHASE1

Sponsor:

TeneoOne Inc.

Location:

Phoenix AZ, Springdale AR, Aurora CO, Newark DEshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383

Elranatamab

Recruiting
PHASE2

Sponsor:

Massachusetts General Hospital

Location:

Boston MA

Code:

NCT06138275

Conditions

Refractory Multiple Myeloma

Relapse Multiple Myeloma

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elranatamab

64Cu-LLP2A

Recruiting
EARLY_PHASE1

Sponsor:

Washington University School of Medicine

Location:

Saint Louis MO

Code:

NCT06636175

Conditions

Multiple Myeloma

Low-Grade Lymphoma

Follicular Lymphoma

Marginal Zone Lymphoma

Lymphoplasmacytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

64Cu-LLP2A

PET/CT

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

MMSET Inhibitor

Recruiting
PHASE1

Sponsor:

K36 Therapeutics, Inc.

Location:

San Francisco CA, Jacksonville FL, Atlanta GA, Boston MAshow 9 more

Code:

NCT05651932

Conditions

Multiple Myeloma

Myeloma

Myeloma Multiple

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cohort A1 & A2

Cohort C1 & C2

Cohort D

Teclistamab & Daratumumab

Recruiting
PHASE2

Sponsor:

Carl Ola Landgren, MD, PhD

Location:

Miami FL

Code:

NCT06100237

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Teclistamab

Talquetamab

Daratumumab SC

JNJ-87562761

Recruiting
PHASE1

Sponsor:

Janssen Research & Development, LLC

Location:

Toronto

Code:

NCT06604715

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JNJ-87562761

Elotuzumab, Daratumumab, Iberdomide, Dexamethasone

Recruiting
PHASE1
PHASE2

Sponsor:

Mayo Clinic

Location:

Rochester MN

Code:

NCT06785415

Conditions

Recurrent Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bone Marrow Aspiration

Bone Marrow Biopsy

Bone Scan

Chest Radiography

Computed Tomography

Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin

Recruiting
PHASE1
PHASE2

Sponsor:

Wake Forest University Health Sciences

Location:

Charlotte NC, Winston Salem NC

Code:

NCT04822337

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Carfilzomib, Lenalidomide, Dexamethasone, Belantamab Mafodotin